You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 162 No. 13, July 8, 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (51)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Evidence-Based Medicine
 •Surgery
 •Orthopedic Surgery
 •Venous Thromboembolism
 •Alert me on articles by topic

Short-Duration Prophylaxis Against Venous Thromboembolism After Total Hip or Knee Replacement

A Meta-analysis of Prospective Studies Investigating Symptomatic Outcomes

James D. Douketis, MD, FRCPC; John W. Eikelboom, MBBS, MSc, FRACP; Daniel J. Quinlan, MBBS; Andrew R. Willan, PhD; Mark A. Crowther, MD, MSc, FRCPC

Arch Intern Med. 2002;162:1465-1471.

Background  The prevalence of asymptomatic deep vein thrombosis diagnosed by venography after hip or knee replacement remains high despite 7 to 10 days of anticoagulant prophylaxis. However, the risk of symptomatic events in such patients is unclear. We performed a meta-analysis to provide reliable estimates of the risk of symptomatic venous thromboembolism occurring within 3 months of hip or knee replacement in patients who received short-duration (7-10 days) anticoagulant prophylaxis.

Methods  The MEDLINE, EMBASE, and Cochrane databases were searched from January1993 to March 2001, supplemented by a manual search of bibliographies and conference abstracts, to identify prospective studies of patients undergoing hip or knee replacement who received short-duration prophylaxis (ie, 7-10 days of fixed-dose low-molecular-weight heparin or adjusted-dose warfarin, with a target international normalized ratio of 2.0-3.0). Studies were classified as clinical outcome studies if the outcome was symptomatic venous thromboembolism or as venographic outcome studies if the outcome was asymptomatic deep vein thrombosis diagnosed after bilateral venography.

Results  There were 4 clinical outcome studies with 6089 patients who had 3 months of follow-up, and 13 venographic outcome studies with 7080 patients who had venography 7 to 10 days after surgery. In clinical outcome studies, the 3-month incidence of nonfatal venous thromboembolism was 3.2% (95% confidence interval [CI], 2.0%-4.4%), and the 3-month incidence of fatal pulmonary embolism was 0.10% (95% CI, 0.02%-0.20%). The postprophylaxis incidence of nonfatal venous thromboembolism was 2.2% (95% CI, 1.4%-3.0%), and the incidence of fatal pulmonary embolism was 0.05% (95% CI, 0%-0.12%). The postprophylaxis incidence of symptomatic venous thromboembolism was higher after hip than after knee replacement (2.5% vs 1.4%; P= .02). In venographic outcome studies, the prevalence of deep vein thrombosis (total and proximal) was higher after knee than after hip replacement (total: 38.8% vs 16.4%; P<.001; proximal: 7.6% vs 3.8%; P<.001).

Conclusions  In patients who undergo hip or knee replacement and receive short-duration anticoagulant prophylaxis, symptomatic nonfatal venous thromboembolism will occur in about 1 of 32 patients and fatal pulmonary embolism will occur in about 1 of 1000 patients within 3 months of the surgery. Although the prevalence of asymptomatic deep vein thrombosis is more than 2-fold higher after knee replacement than after hip replacement 7 to 10 days after surgery, in the subsequent 3 months, symptomatic venous thromboembolism is more likely to occur after hip replacement.


From the Departments of Medicine, McMaster University, and St Joseph's Hospital, Hamilton, Ontario (Drs Douketis and Crowther); the Department of Hematology, Royal Perth Hospital, Perth, Australia (Dr Eikelboom); the Department of Radiology, King's College Hospital, London, England (Dr Quinlan); and the Department of Clinical Epidemiology and Biostatistics, McMaster University (Dr Willan).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Burden of Deep Vein Thrombosis in the Outpatient Setting Following Major Orthopedic Surgery
Nutescu et al.
The Annals of Pharmacotherapy 2008;42:1216-1221.
ABSTRACT | FULL TEXT  

Postdischarge Oral Versus Injectable Anticoagulation Following Major Orthopedic Surgery
Shorr et al.
The Annals of Pharmacotherapy 2008;42:1222-1228.
ABSTRACT | FULL TEXT  

Prevention of Venous Thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Geerts et al.
Chest 2008;133:381S-453S.
ABSTRACT | FULL TEXT  

Author's reply
WARWICK
J Bone Joint Surg Br 2007;89-B:1409-1410.
FULL TEXT  

Venous Thromboembolism in the Outpatient Setting
Spencer et al.
Arch Intern Med 2007;167:1471-1475.
ABSTRACT | FULL TEXT  

Consultative hematology
McCrae et al.
ASH-SAP 2007;2007:466-505.
FULL TEXT  

Perioperative management of the obese orthopaedic patient.
Guss and Bhattacharyya
J Am Acad Orthop Surg 2006;14:425-432.
ABSTRACT | FULL TEXT  

Prevention of postoperative venous thromboembolism. Risk assessment and methods of prophylaxis: [La prevention de la thromboembolie veineuse postoperatoire. Evaluation du risque et methodes de prophylaxie]
Motte et al.
Canadian J. Anesthesia 2006;53:S68-S79.
ABSTRACT | FULL TEXT  

Frequency and timing of clinical venous thromboembolism after major joint surgery
Bjornara et al.
J Bone Joint Surg Br 2006;88-B:386-391.
ABSTRACT | FULL TEXT  

Venous thromboembolism associated with hip and knee replacement over a ten-year period: A POPULATION-BASED STUDY
Howie et al.
J Bone Joint Surg Br 2005;87-B:1675-1680.
ABSTRACT | FULL TEXT  

Identifying Orthopedic Patients at High Risk for Venous Thromboembolism Despite Thromboprophylaxis
Schiff et al.
Chest 2005;128:3364-3371.
ABSTRACT | FULL TEXT  

Low-Dose Warfarin for Prevention of Symptomatic Thromboembolism After Orthopedic Surgery
Enyart and Jones
The Annals of Pharmacotherapy 2005;39:1002-1007.
ABSTRACT | FULL TEXT  

New anticoagulants
Hirsh et al.
Blood 2005;105:453-463.
ABSTRACT | FULL TEXT  

Prevention of Venous Thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Geerts et al.
Chest 2004;126:338S-400S.
ABSTRACT | FULL TEXT  

Superiority of Fondaparinux Over Enoxaparin in Preventing Venous Thromboembolism in Major Orthopedic Surgery Using Different Efficacy End Points
Turpie et al.
Chest 2004;126:501-508.
ABSTRACT | FULL TEXT  

Deep Vein Thrombosis in Elderly Patients Hospitalized in Subacute Care Facilities: A Multicenter Cross-sectional Study of Risk Factors, Prophylaxis, and Prevalence
Bosson et al.
Arch Intern Med 2003;163:2613-2618.
ABSTRACT | FULL TEXT  

Natural History of Venous Thromboembolism
Kearon
Circulation 2003;107:I-22-30.
ABSTRACT | FULL TEXT  

OTHER ARTICLES NOTED (Nov 01 to 18 Oct 02)
Evid. Based Nurs. 2003;6:e1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.